Viracta Therapeutics Inc's Comment on Supply Chain
The company utilizes contract manufacturers to produce materials in compliance with FDA, EMA, and other regulatory standards. Failure by these manufacturers to maintain quality control or regulatory approvals may require the company to secure alternative manufacturing facilities, potentially causing delays in product development and commercialization. The company holds a license agreement with ImmunityBio, Inc., formerly NantKwest, Inc., for the development and commercialization of nanatinostat. This agreement includes collaboration on clinical trials and regulatory approvals, with ImmunityBio responsible for conducting the necessary studies and trials to obtain regulatory approval for the licensed products.
Viracta Therapeutics Inc's Comment on Supply Chain
The company utilizes contract manufacturers to produce materials in compliance with FDA, EMA, and other regulatory standards. Failure by these manufacturers to maintain quality control or regulatory approvals may require the company to secure alternative manufacturing facilities, potentially causing delays in product development and commercialization. The company holds a license agreement with ImmunityBio, Inc., formerly NantKwest, Inc., for the development and commercialization of nanatinostat. This agreement includes collaboration on clinical trials and regulatory approvals, with ImmunityBio responsible for conducting the necessary studies and trials to obtain regulatory approval for the licensed products.
Sources:
Viracta Therapeutics Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Viracta Therapeutics Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
